GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (TPE:6919) » Definitions » EBITDA Margin %

Caliway Biopharmaceuticals Co (TPE:6919) EBITDA Margin % : -518.37% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Caliway Biopharmaceuticals Co's EBITDA for the three months ended in Dec. 2024 was NT$-48.54 Mil. Caliway Biopharmaceuticals Co's Revenue for the three months ended in Dec. 2024 was NT$9.36 Mil. Therefore, Caliway Biopharmaceuticals Co's EBITDA margin for the quarter that ended in Dec. 2024 was -518.37%.


Caliway Biopharmaceuticals Co EBITDA Margin % Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co EBITDA Margin % Chart

Caliway Biopharmaceuticals Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial -731.25 -1,605.37 -2,029.27 -1,181.78 -1,258.03

Caliway Biopharmaceuticals Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -744.83 -5,324.13 -2,157.45 -558.91 -518.37

Competitive Comparison of Caliway Biopharmaceuticals Co's EBITDA Margin %

For the Biotechnology subindustry, Caliway Biopharmaceuticals Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliway Biopharmaceuticals Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caliway Biopharmaceuticals Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Caliway Biopharmaceuticals Co's EBITDA Margin % falls into.


;
;

Caliway Biopharmaceuticals Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Caliway Biopharmaceuticals Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-558.993/44.434
=-1,258.03 %

Caliway Biopharmaceuticals Co's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-48.535/9.363
=-518.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caliway Biopharmaceuticals Co  (TPE:6919) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Caliway Biopharmaceuticals Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Caliway Biopharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221
Caliway Biopharmaceuticals Co Ltd is specialized in the development of new drugs for medical aesthetic and inflammatory diseases. Its pipeline candidate is, CBL-514, CBA-539, and CBO-012.

Caliway Biopharmaceuticals Co Headlines

No Headlines